Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Pathogenesis of type 2 diabetes: implications for metformin.

× No keyword cloud information.

13 in total

1. Metabolic effects of metformin on glucose and lactate metabolism in noninsulin-dependent diabetes mellitus.

Authors: K Cusi; A Consoli; R A DeFronzo
Journal: J Clin Endocrinol Metab Date: 1996-11 Impact factor: 5.958

Review 2. Lilly lecture 1987. The triumvirate: beta-cell, muscle, liver. A collusion responsible for NIDDM.

Authors: R A DeFronzo
Journal: Diabetes Date: 1988-06 Impact factor: 9.461

3. Efficacy and metabolic effects of metformin and troglitazone in type II diabetes mellitus.

Authors: S E Inzucchi; D G Maggs; G R Spollett; S L Page; F S Rife; V Walton; G I Shulman
Journal: N Engl J Med Date: 1998-03-26 Impact factor: 91.245

4. Efficacy of metformin in type II diabetes: results of a double-blind, placebo-controlled, dose-response trial.

Authors: A J Garber; T G Duncan; A M Goodman; D J Mills; J L Rohlf
Journal: Am J Med Date: 1997-12 Impact factor: 4.965

5. Pathogenesis of NIDDM. A balanced overview.

Authors: R A DeFronzo; R C Bonadonna; E Ferrannini
Journal: Diabetes Care Date: 1992-03 Impact factor: 19.112

6. Metformin for obese, insulin-treated diabetic patients: improvement in glycaemic control and reduction of metabolic risk factors.

Authors: D Giugliano; A Quatraro; G Consoli; A Minei; A Ceriello; N De Rosa; F D'Onofrio
Journal: Eur J Clin Pharmacol Date: 1993 Impact factor: 2.953

7. The metabolic profile of NIDDM is fully established in glucose-tolerant offspring of two Mexican-American NIDDM parents.

Authors: G Gulli; E Ferrannini; M Stern; S Haffner; R A DeFronzo
Journal: Diabetes Date: 1992-12 Impact factor: 9.461

8. Efficacy of metformin in patients with non-insulin-dependent diabetes mellitus. The Multicenter Metformin Study Group.

Authors: R A DeFronzo; A M Goodman
Journal: N Engl J Med Date: 1995-08-31 Impact factor: 91.245

9. Predominant role of gluconeogenesis in increased hepatic glucose production in NIDDM.

Authors: A Consoli; N Nurjhan; F Capani; J Gerich
Journal: Diabetes Date: 1989-05 Impact factor: 9.461

10. Fasting hyperglycemia in non-insulin-dependent diabetes mellitus: contributions of excessive hepatic glucose production and impaired tissue glucose uptake.

Authors: R A DeFronzo; E Ferrannini; D C Simonson
Journal: Metabolism Date: 1989-04 Impact factor: 8.694

4 in total

1. Metformin for primary colorectal cancer prevention in patients with diabetes: a case-control study in a US population.

Authors: Amikar Sehdev; Ya-Chen T Shih; Benjamin Vekhter; Marc B Bissonnette; Olufunmilayo I Olopade; Blase N Polite
Journal: Cancer Date: 2014-11-25 Impact factor: 6.860

2. Inonotus obliquus polysaccharide ameliorates serum profiling in STZ-induced diabetic mice model.

Authors: Tanye Xu; Guodao Li; Xiaobo Wang; Chongning Lv; Yuanyong Tian
Journal: BMC Chem Date: 2021-12-17

3. The efficacy and safety of saxagliptin when added to metformin therapy in patients with inadequately controlled type 2 diabetes with metformin alone.

Authors: Ralph A DeFronzo; Miguel N Hissa; Alan J Garber; Jorge Luiz Gross; Raina Yuyan Duan; Shoba Ravichandran; Roland S Chen
Journal: Diabetes Care Date: 2009-05-28 Impact factor: 19.112

4. Comparison of glycemic control and β-cell function in new onset T2DM patients with PCOS of metformin and saxagliptin monotherapy or combination treatment.

Authors: Tao Tao; Peihong Wu; Yuying Wang; Wei Liu
Journal: BMC Endocr Disord Date: 2018-02-27 Impact factor: 2.763

4 in total